Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Alimentary Pharmacology & Therapeutics|August 28, 2025
Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular CarcinomaAshwini Arvind, Hiroaki Kanzaki, Fouzia Ahmed, et al.
Journal of Hepatology|December 3, 2014
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Nabeel Bardeesy, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2026
Net benefit of surveillance varies by hepatocellular carcinoma risk in patients with cirrhosisAkash Patel, Elena Gavrila, Sruthi Yekkaluri, et al.
Oncology Reports|October 8, 2005
Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysisYousuke Nakai, Motoyuki Otsuka, Yujin Hoshida, et al.
International Journal of Oncology|October 20, 2004
Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapyMasaru Moriyama, Yujin Hoshida, Naoya Kato, et al.
Gut and Liver|July 8, 2025
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical modelsRomain Desert, Fabio Gianonne, Antonio Saviano, et al.
Hepato-Gastroenterology|May 9, 2002
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinomaYujin Hoshida, Yasushi Shiratori, Yukihiro Koike, et al.
Hepato-Gastroenterology|May 26, 2007
Gene expressions associated with chemosensitivity in human hepatoma cellsYujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2004
A simple combination of serum type IV collagen and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis CYi Qiu, Yujin Hoshida, Naoya Kato, et al.
Development (Cambridge, England)|January 8, 2015
DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish embryosVinitha Jacob, Yelena Chernyavskaya, Xintong Chen, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Alimentary Pharmacology & Therapeutics|August 28, 2025
Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular CarcinomaAshwini Arvind, Hiroaki Kanzaki, Fouzia Ahmed, et al.
Journal of Hepatology|December 3, 2014
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Nabeel Bardeesy, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2026
Net benefit of surveillance varies by hepatocellular carcinoma risk in patients with cirrhosisAkash Patel, Elena Gavrila, Sruthi Yekkaluri, et al.
Oncology Reports|October 8, 2005
Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysisYousuke Nakai, Motoyuki Otsuka, Yujin Hoshida, et al.
International Journal of Oncology|October 20, 2004
Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapyMasaru Moriyama, Yujin Hoshida, Naoya Kato, et al.
Gut and Liver|July 8, 2025
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical modelsRomain Desert, Fabio Gianonne, Antonio Saviano, et al.
Hepato-Gastroenterology|May 9, 2002
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinomaYujin Hoshida, Yasushi Shiratori, Yukihiro Koike, et al.
Hepato-Gastroenterology|May 26, 2007
Gene expressions associated with chemosensitivity in human hepatoma cellsYujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2004
A simple combination of serum type IV collagen and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis CYi Qiu, Yujin Hoshida, Naoya Kato, et al.
Development (Cambridge, England)|January 8, 2015
DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish embryosVinitha Jacob, Yelena Chernyavskaya, Xintong Chen, et al.
Pageof 27